» Articles » PMID: 10967024

Creating HIV-1 Reverse Transcriptase Cytotoxic T Lymphocyte Target Structures by HLA-A2 Heavy Chain Modifications

Overview
Journal Int Immunol
Date 2000 Sep 1
PMID 10967024
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Vigorous HIV-1-specific CD8(+) cytotoxic T lymphocyte (CTL) responses play an important role in the control of HIV-1 replication and the induction of a strong, broadly cross-reactive CTL response remains an important goal of HIV vaccine development. It is known that the display of high levels of class I MHC-viral peptide complexes at the cell surface of target cells is necessary to elicit a strong CTL response. We now report two strategies to enhance the presentation of defined HIV-1 epitope-specific CTL target structures, by incorporating subdominant HIV-1 reverse transcriptase (RT) CTL epitope sequences into the human class I MHC molecule HLA-A2. We show that either incorporation of HIV-1 CTL epitopes into the signal sequence of HLA or tethering of epitopes to the HLA-A2 heavy chain provide simple ways to create effective CTL target structures that can be recognized and lysed by human HLA-A2-restricted RT-specific CD8(+) CTL. Moreover, cells expressing these epitope-containing HLA-A2 constructs stimulated the generation of primary epitope-specific CTL in vitro. These strategies offer new options in the design of plasmid DNA-based vaccines or immunotherapeutics for the induction of CTL responses against subdominant HIV-1 epitopes.

Citing Articles

Properties and applications of single-chain major histocompatibility complex class I molecules.

Kotsiou E, Brzostek J, Gould K Antioxid Redox Signal. 2010; 15(3):645-55.

PMID: 21126187 PMC: 3125553. DOI: 10.1089/ars.2010.3694.


Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory....

Joseph A, Zheng J, Follenzi A, Dilorenzo T, Sango K, Hyman J J Virol. 2008; 82(6):3078-89.

PMID: 18184707 PMC: 2258988. DOI: 10.1128/JVI.01812-07.


Exciting applications of single chain trimers of MHC-I molecules.

Hansen T, Lybarger L Cancer Immunol Immunother. 2005; 55(2):235-6.

PMID: 16261380 PMC: 11030785. DOI: 10.1007/s00262-005-0091-9.


Applications of major histocompatibility complex class I molecules expressed as single chains.

Primeau T, Myers N, Yu Y, Lybarger L, Wang X, Truscott S Immunol Res. 2005; 32(1-3):109-21.

PMID: 16106063 DOI: 10.1385/ir:32:1-3:109.